HANSOH PHARMA (03692) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Hansoh Pharmaceutical Group Company Limited (HKG:3692) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
Simply Wall StJan 8 20:05 ET
Express News | Hansoh Pharmaceutical - Hs-20093 Received FDA Breakthrough Therapy Designation in Late-Line Relapsed or Refractory Osteosarcoma
ReutersJan 7 06:16 ET
China Healthcare Sector to Get Policy Boost in 1Q -- Market Talk
WSJJan 7 03:23 ET
Hansoh Pharmaceutical Units Sign Up to $2 Billion Licensing Deal for Weight Loss Drug Candidate
MT NewswiresDec 19, 2024 21:57 ET
Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Popularity With Investors Is Under Threat From Overpricing
Simply Wall StDec 18, 2024 17:58 ET
Viking Shares Tumble After Merck Inks Deal With Hansoh Pharma
InvestingDec 18, 2024 08:14 ET

Comments

Bull X Bear

Oct 3, 2024 02:14

What would you buy in your Hong Kong portfolio?

Banks: $ABC (01288.HK)$ $BANK OF CHINA (03988.HK)$
Securities & Brokerage: $HTSC (06886.HK)$ $CMSC (06099.HK)$
Gaming Software: $NTES-S (09999.HK)$ $XD INC (02400.HK)$ $NETDRAGON (00777.HK)$
Digital Solutions: $TENCENT (00700.HK)$ $TRAVELSKY TECH (00696.HK)$ $CHINASOFT INT'L (00354.HK)$
Online Retailer: $BABA-W (09988.HK)$ $MEITUAN-W (03690.HK)$ $JD-SW (09618.HK)$
Insurer: $PING AN (02318.HK)$ $AIA (01299.HK)$ $CHINA LIFE (02628.HK)$
Telecommunication: $CHINA MOBILE (00941.HK)$ $CHINA TELECOM (00728.HK)$
...

Officials say the real estate market is bottoming out. What’s your view on China's property market?

15

7

Trader’s Edge

Sep 25, 2024 06:05

Columns Chinese Market Blitzkrieg: Is it any different this time?

Background
Chinese indices have been ripping higher the past 2 days. To put things in perspective, this is only the 2nd time in 2024 (and since Jan 2023) where we see the onshore indices post a bigger rally than the HSI.
1st Time (February 2024):CSI 300 was up by+10% while the HSI was up by only +7.7%
2nd Time (September 2024):CSI 300 up by+6.3% while the HSI was up by only +4.9%
So... what led to this sudden outperformance?
On 24th Septem...

+2

Officials say the real estate market is bottoming out. What’s your view on China's property market?

42

4

9

Trader’s Edge

Sep 8, 2024 21:56

Columns Stocks we're watching this week - KMB, MET and more

Stocks to Watch
Kimberly-Clark Corporation (KMB US) $Kimberly-Clark (KMB.US)$
Daily Chart -[BULLISH ↗ **]KMB is holding above mid-term ascending trendline support and hasbeen making a series of higher highs and higher lows. As long as price is holding above 142 support, a further push higher towards 155.70 resistance is expected. Technical indicators are advocating for a bullish scenario.
Alternatively: A daily candlestick closingbelow 142 suppor...

+3

20

Moomoo AI

Mar 4, 2024 16:46

Hansoh Pharmaceutical Group's high P/E ratio may be due to expected earnings recovery. However, with lower than market growth forecast, the high P/E ratio and positive investor sentiment may not be sustainable. Current trading prices may not be reasonable without significant improvement.

Optimistic Investors Push Hansoh Pharmaceutical Group Company Limited (HKG:3692) Shares Up 28% But Growth Is Lacking

1

Moomoo AI

Feb 11, 2024 22:53

Hansoh Pharmaceutical Group's strong financials and moderate growth over the past five years, along with its high rate of profit reinvestment, could potentially boost its stock value in the long-term. Analysts anticipate future earnings momentum.

Hansoh Pharmaceutical Group Company Limited (HKG:3692) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

03692 HANSOH PHARMA

Trade Overview

Capital Trend

News

Comments